Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Classement en actions #33689
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Prix de l'action
$4.70
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.09M
Changement (1 jour)
-0.21%
Changement (1 an)
-70.63%
Pays
US
Échange Apimeds Pharmaceuticals US, Inc (APUS)

Catégorie

Le prix APUS avec la capitalisation boursière de B
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
APUS
$4.70
Capitalisation boursière de Apimeds Pharmaceuticals US, Inc(APUS)
Capitalisation boursière: $7.09M
En August 2026, Apimeds Pharmaceuticals US, Inc a une capitalisation boursière de $7.09M. Cela fait de Apimeds Pharmaceuticals US, Inc la 33689th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Apimeds Pharmaceuticals US, Inc du 2025 au 2026
APUS par rapport au top 5 des plus populaires stocks
Prix pour APUS L’actif B La capitalisation boursière de B Résultats
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$3,612,485 $7.09M
$5.452T +76,861,285.15%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$2,975,151 $7.09M
$4.490T +63,300,989.91%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$2,758,070 $7.09M
$4.162T +58,682,242.40%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$2,435,997 $7.09M
$3.676T +51,829,618.92%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$1,877,214 $7.09M
$2.833T +39,940,630.60%